KL and chronic kidney disease: Studies have shown that IMD1-53 may attenuate VC in CKD by upregulating α-Klotho, and IMD could alleviate vitamin D3 plus nicotine (VDN)-induced VC by increasing the level of matrix gamma-carboxyglutamic acid protein (58, 59).